Compare AU
Compare DRUG vs. HETH
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare ETF - Currency Hedged (DRUG) and the BetaShares Global Sustainability Leaders ETF - Ch (HETH). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
DRUG | HETH | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 63 | 31 |
Median incremental investment | $967.00 | $1,992.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,905.75 | $4,118.08 |
Average age group | 26 - 35 | > 35 |
Key Summary
DRUG | HETH | |
|---|---|---|
Strategy | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. | HETH.AX was created on 2020-07-20 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to track the performance of an index (before fees and expenses) that provides exposure to 200 large global stocks (excluding Australia). |
Top 3 holdings | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) | NVIDIA CORP (5.40 %) APPLE INC (5.28 %) VISA INC (3.73 %) |
Top 3 industries | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) | Information Technology (27.64 %) Other (23.81 %) Financials (18.23 %) |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | United States (77.55 %) Japan (7.54 %) Netherlands (3.82 %) |
Management fee | 0.57 % | 0.62 % |
Key Summary
DRUG | HETH | |
|---|---|---|
Issuer | BetaShares | BetaShares |
Tracking index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | Nasdaq Future Global Sustainability Leaders Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.57 % | 0.62 % |
Price | $8.25 | $15.14 |
Size | $182.401 million | $559.450 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 1.90 % | 2.53 % |
Market | ASX | ASX |
First listed date | 08/08/2016 | 21/07/2020 |
Purchase fee | $6.50 | $6.50 |
Community Stats
DRUG | HETH | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 63 | 31 |
Median incremental investment | $967.00 | $1,992.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,905.75 | $4,118.08 |
Average age group | 26 - 35 | > 35 |
Pros and Cons
DRUG | HETH | |
|---|---|---|
Pros |
|
|
Cons |
|
|
DRUG | HETH |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Lower distribution yield | Higher distribution yield |